← Eichor
Condition: Treatment For Opioid Use Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Treatment For Opioid Use Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Semaglutide for Helping Opioid Recovery
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT06639464
Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NA · 1 location(s) · Emory University · NCT05711056
Translation and Validation of the COMM and ASI-SR
Phase N/A · 1 location(s) · Uppsala University · NCT06084520
Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
NA · 1 location(s) · Potomac Health Foundations · NCT06774248
Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826
Optimization of NIBS for Treatment of Addiction
NA · 3 location(s) · Case Western Reserve University · NCT04379115
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prev
NA · 1 location(s) · Chestnut Health Systems · NCT06852170
Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso
NA · 1 location(s) · Geisinger Clinic · NCT07197801
Disclosure Intervention for People in Treatment for Opioid Use Disorder
NA · 1 location(s) · University of Delaware · NCT06458985
Mobile Platform for Optimizing Wellness and Engagement in Recovery
NA · 1 location(s) · University of Michigan · NCT07178990
Integrated Treatment for Opioid Use Disorder and PTSD
NA · 1 location(s) · Medical University of South Carolina · NCT06641115
Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based Practices
NA · 1 location(s) · Prisma Health-Upstate · NCT07541417
Divided or Single Exposure (DOSE) Study
Phase 2/Phase 3 · 1 location(s) · University of Maryland, Baltimore · NCT05459402
IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs
NA · 1 location(s) · Albert Einstein College of Medicine · NCT05492825
Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation
NA · 1 location(s) · Baystate Medical Center · NCT06527820
Adaptive Decision Support for Addiction Treatment Master
NA · 3 location(s) · Yale University · NCT06799117
A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for t
NA · 4 location(s) · OpiAID · NCT07405398
The Youth Opioid Recovery Support (YORS) Intervention
NA · 1 location(s) · Potomac Health Foundations · NCT04173416
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implica
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT06104280
Psilocybin for Opioid Use Disorder (OUD)
Phase 2 · 5 location(s) · NYU Langone Health · NCT06796062
Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treat
Phase 2 · 1 location(s) · Washington State University · NCT06323837
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305
Phase 3 · 11 location(s) · Merck Sharp & Dohme LLC · NCT06655883
Deep Brain Stimulation Effects In Patients With Opioid Use Disorder
NA · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT04354077
Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment
NA · 1 location(s) · University of Arkansas · NCT07071766
LIFU for Treatment for Refractory Opioid Use Disorder
NA · 1 location(s) · Ali Rezai · NCT06218706
Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial
Phase 4 · 2 location(s) · Pouya Azar · NCT07439549
Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
Phase 2 · 1 location(s) · BC Centre on Substance Use · NCT05985850
Focused Ultrasound for the Complex Patient
NA · 1 location(s) · Washington D.C. Veterans Affairs Medical Center · NCT06453109
M2VA Pain Care Pathway
NA · 1 location(s) · Yale University · NCT06526143
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
NA · 1 location(s) · Medical University of South Carolina · NCT06157840
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.